Last reviewed · How we verify
esomeprazole 40 mg
Esomeprazole 40 mg, marketed by Far Eastern Memorial Hospital, is a proton pump inhibitor with a key composition patent expiring in 2028. The drug's primary strength lies in its well-established mechanism and market presence, positioning it as a reliable treatment option. The primary risk is the potential increase in generic competition following the 2028 patent expiry, which could erode market share and revenue.
At a glance
| Generic name | esomeprazole 40 mg |
|---|---|
| Also known as | Nexium, Nexium 40mg, Ezogast, No comparator |
| Sponsor | Far Eastern Memorial Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers (PHASE4)
- A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks (NA)
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU
- Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease (PHASE3)
- Heartburn, Gastroesophageal Reflux Disease (PHASE4)
- Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination (PHASE1)
- Acid-suppression Drugs After Prophylactic Endoscopic Variceal Treatment of Esophagogastric Variceal Bleeding in Cirrhosis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- esomeprazole 40 mg CI brief — competitive landscape report
- esomeprazole 40 mg updates RSS · CI watch RSS
- Far Eastern Memorial Hospital portfolio CI